hims & hers fda warning letter compounded semaglutide 2025 From a new Perspective by Amanda Banks, MD: On February 5, 2026, Hers, an online health and wellness platform, announced its intention to sell oral semaglutide, a glucagon-like peptide-1 ( Hims & Hers' Woes Compound

If youre taking injectable GLP-1 medications like Mounjaro or Wegovy, youve probably noticed a reduced appetite which is exactly how these treatments help support weight loss

Compounded GLP-1 medications are typically much cheaper than their branded counterparts

Some compounders had been mass compounding semaglutide tablets in the absence of an FDA-approved alternative but were generally expected to discontinue the practice once an FDA-approved version was available on the market

She gets personalized dosing through a telehealth platform

Antioxidants and microalgae: This dynamic duo forms a protective shield that wards off environmental aggressors and oxidative stress, key factors in accelerated skin aging